High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: missed opportunities for hepatitis C testing

• Päätekijät: Julia Enkelmann (Tekijä), Martyna Gassowski (Tekijä), Stine Nielsen (Tekijä), Benjamin Wenz (Tekijä), Stefan Roß (Tekijä), Ulrich Marcus (Tekijä), Viviane Bremer (Tekijä), Ruth Zimmermann (Tekijä), DRUCK Study group (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2020-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background In Germany, risk of hepatitis C virus (HCV) infection is highest among people who inject drugs (PWID). New injectors (NI) are particularly vulnerable for HCV-acquisition, but little is known about health seeking behaviour and opportunities for intervention in this group. We descr...